DUBLIN--(BUSINESS WIRE)--The "Bioburden Testing Market by Product, Test, Application, End User - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering. The bioburden ...
Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology. This agreement expands Lonza’s extensive offering of ...
Methods to Simultaneously Reduce Bioburden and Maintain Column Integrity, Explained Continuous bioprocessing is inevitably becoming the future of biomanufacturing. To date, several steps within a ...
New York, October 08, 2021 – Reports and Data has published its latest report titled “bioburden testing market By Type (Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma), By Application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results